Option chain shows key data for Biomind Labs's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Biomind Labs.

Biomind Labs (OTC:BMNDF) Stock, Option Chain

Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.

Cannabis

News

Penny Stocks

Psychedelics

Markets

BMNDF

Psychedelics R&amp;D biotech Biomind Labs Inc.

New Sublingual Psychedelic Drug Candidate Created For Depression And Anxiety In Alzheimer&#39;s

AGNPF

CMND

CMPS

CYBN

KONEF

MSSTF

MYDECINE INNOV GRP by MYDECINE INNOVATIONS GROUP INC.

MYCOF

PSIL

PSYK

REUN

RVLWF

TSLA

Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy



Psyched: Musk&#39;s Empathy Tweets, Psychedelics In Congress, Oregon&#39;s Opt-Outs, MAPS&#39; MDMA Trial And More

Earnings

Next-gen psychedelics developer Biomind Labs Inc.

Biomind Labs: Q3 Financials &amp; FDA Approval For New Chemical Entity Targeting Treatment-Resistant Depression

Biomind Labs Inc

Biotech

Press Releases

Biomind Labs To Redefine Obesity Treatment With Its New BMND06 Candidate Targeting Neurological Pathways

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

Biomind Labs

Comments

Biomind Labs

Biomind Labs (BMNDF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell